Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Guardado en:
Autores principales: | Chee Fu Yung, Xiangmei Ma, Yin Bun Cheung, Bee Khiam Oh, Sally Soh, Koh Cheng Thoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e287d587cf69401fba8320f327b4f722 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
por: Yan Li, et al.
Publicado: (2021) -
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
por: Pasiarski M, et al.
Publicado: (2019) -
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.
por: C Raina Macintyre, et al.
Publicado: (2014) -
Virulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccine.
por: Nelson Frazão, et al.
Publicado: (2013) -
Pneumococcal conjugate vaccines: New hope for infancy
por: Black,Steven B., et al.
Publicado: (2001)